Diabetes Care Devices Market Scope And Analysis

  • Report Code : TIPRE00003753
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 190
Buy Now

Diabetes Care Devices Market Analysis, Scope, and Growth by 2028

Buy Now


Diabetes Care Devices Market Report Scope

Report Attribute Details
Market size in 2022 US$ 28.94 Billion
Market Size by 2028 US$ 42.12 Billion
Global CAGR (2022 - 2028) 4.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Glucose Monitoring Devices and Insulin Delivery Devices
By End User
  • Homecare and Hospitals & Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BD
  • Novo Nordisk A S
  • B Braun Melsungen AG
  • Medtronic
  • Tandem Diabetes Care Inc
  • Insulet Corporation
  • Eli Lilly and Company
  • DEXCOM INC
  • Terumo Corporation
  • Covid-19 Impact: 

    The COVID-19 pandemic affected economies and industries in various countries across the globe. Lockdowns, travel restrictions, and business shutdowns in North America, Europe, Asia Pacific (APAC), South & Central America (SAM), and the Middle East & Africa (MEA) hampered the growth of several industries, including the healthcare industry. As a result, health care systems are overburdened, and the delivery of medical care to all patients has become a challenge in the region. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering diabetes care devices have their business operations in the United States and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of company’s facilities. However, gradually hospitals have started resuming elective procedures as the COVID-19 recovery rate is increasing the demand for medical equipment like diabetes care is expected to increase.

    Competitive Landscape and Key Companies:

    Some of the prominent players operating in the global diabetes care devices market include BD; Novo Nordisk A/S; Medtronic; B. Braun Melsungen AG; Tandem Diabetes Care Inc.; Insulet Corporation; Eli Lilly and Company; Dexcom, Inc.; Terumo Corporation; F. Hoffmann-LA Roche LTD among others. These diabetes device companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share. The report offers trend analysis of the diabetes care device market emphasizing on various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.